Showing 61–72 of 108 results

  • Janumet 50\1000mg 56tablets

    Janumet 50\1000mg 56tablets

    0 out of 5
    EGP674

    Medication Name: Janumet 50/1000 mg 56 Tablets Active Ingredients:Sitagliptin 50 mgMetformin Hydrochloride 1000 mg Pharmacological Class:Dipeptidyl Peptidase-4 (DPP-4) inhibitor + Biguanide combination Indication:Used to improve glycemic control in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise, particularly when monotherapy with sitagliptin or metformin is insufficient. Dosage:Usually, one tablet taken twice…

  • Janumet 50\500mg 56tablets

    Janumet 50\500mg 56tablets

    0 out of 5
    EGP618

    Medication Name: Janumet 50/500 mg 56 Tablets Active Ingredients:Sitagliptin 50 mgMetformin Hydrochloride 500 mg Pharmacological Class:Dipeptidyl Peptidase-4 (DPP-4) inhibitor + Biguanide combination Indication:For the treatment of type 2 diabetes mellitus in adults to improve glycemic control when diet, exercise, and metformin or sitagliptin alone do not provide adequate control. Dosage:Typically, one tablet taken twice daily…

  • Jardiance 10mg 30tablets

    Jardiance 10mg 30tablets

    0 out of 5
    EGP626

    Medication Name: Jardiance 10mg 30 Tablets Active Ingredient:Empagliflozin 10 mg Pharmacological Class:SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor Indication: Management of type 2 diabetes mellitus to improve blood glucose control in adults. Reduction of cardiovascular death risk in adults with type 2 diabetes and established cardiovascular disease. Treatment of chronic heart failure (both reduced and preserved ejection…

  • Jardiance 25mg 30tablets

    Jardiance 25mg 30tablets

    0 out of 5
    EGP626

    Medication Name: Jardiance 25mg 30 Tablets Active Ingredient:Empagliflozin 25 mg Pharmacological Class:SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor Indication: Management of type 2 diabetes mellitus to improve glycemic control in adults. Reduction of cardiovascular death risk in adults with type 2 diabetes and established cardiovascular disease. Treatment of heart failure with reduced or preserved ejection fraction. Dosage:One…

  • Lantus Solostar 100iu/ml 5 pens

    Lantus Solostar 100iu/ml 5 pens

    0 out of 5
    EGP1,244

    Medication Name: Lantus SoloStar 100 IU/ml 5 Pens Active Ingredient:Insulin Glargine 100 IU/ml Pharmacological Class:Long-acting insulin analog Indication:Used in adults, adolescents, and children with type 1 or type 2 diabetes mellitus to improve glycemic control. Provides a steady basal insulin level for 24 hours. Dosage:The dose is individualized based on blood glucose monitoring, dietary intake,…

  • Maxophage 1000 XR 30 Tablets

    Maxophage 1000 XR 30 Tablets

    0 out of 5
    EGP72

    Medication Name: Maxophage 1000 XR 30 TabletsActive Ingredient: Metformin Hydrochloride 1000 mg (extended-release) Pharmacological Class: Biguanide antidiabetic agent Indications: Type 2 diabetes mellitus (to improve glycemic control) May be used alone or with other antidiabetic agents (such as insulin, sulfonylureas, DPP-4 inhibitors, or GLP-1 agonists) Dosage Form: Extended-release tablets (XR) Typical Dose and Use: Starting…

  • Mellitofix 10mg 30tablets

    Mellitofix 10mg 30tablets

    0 out of 5
    EGP204

    Medication Name: Mellitofix 10mg 30 Tablets Active Ingredient:Empagliflozin 10 mg Pharmacological Class:SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor Indication:Used in adults with type 2 diabetes mellitus to improve blood glucose control, either alone or in combination with other antidiabetic medications.Also indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular…

  • Mellitofix 25mg 30tablets

    Mellitofix 25mg 30tablets

    0 out of 5
    EGP303

    Medication Name: Mellitofix 25mg 30 Tablets Active Ingredient:Empagliflozin 25 mg Pharmacological Class:SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor Indication:Used in adults with type 2 diabetes mellitus to improve blood glucose control, as monotherapy or in combination with other antidiabetic medications.Also indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular…

  • Mellitofix Met 1000/12.5mg 30tablets

    Mellitofix Met 1000/12.5mg 30tablets

    0 out of 5
    EGP295

    Medication Name: Mellitofix Met 1000/12.5mg 30 Tablets Active Ingredients: Empagliflozin 12.5 mg Metformin Hydrochloride 1000 mg Pharmacological Class:Combination of SGLT2 inhibitor and biguanide antidiabetic agent Indication:Used in adults with type 2 diabetes mellitus to improve glycemic control when combined therapy with empagliflozin and metformin is appropriate, alongside proper diet and exercise. Dosage:Typically one tablet once…

  • Mellitofix Met 1000/5mg 30tablets

    Mellitofix Met 1000/5mg 30tablets

    0 out of 5
    EGP163.50

    Medication Name: Mellitofix Met 1000/5mg 30 Tablets Active Ingredients: Empagliflozin 5 mg Metformin Hydrochloride 1000 mg Pharmacological Class:Combination of SGLT2 inhibitor and biguanide antidiabetic agent Indication:Used in adults with type 2 diabetes mellitus to improve blood glucose control when combination therapy with empagliflozin and metformin is appropriate, as an adjunct to diet and exercise. Dosage:One…

  • Mellitofix Met 500/12.5mg 30tablets

    Mellitofix Met 500/12.5mg 30tablets

    0 out of 5
    EGP193.50

    Medication Name: Mellitofix Met 500/12.5mg 30 Tablets Active Ingredients: Empagliflozin 12.5 mg Metformin Hydrochloride 500 mg Pharmacological Class:Combination of SGLT2 inhibitor and biguanide antidiabetic agent Indication:Indicated for adults with type 2 diabetes mellitus to improve glycemic control when dual therapy with empagliflozin and metformin is suitable, as an adjunct to diet and physical activity. Dosage:One…

  • Mellitofix Met 500/5mg 30tablets

    Mellitofix Met 500/5mg 30tablets

    0 out of 5
    EGP112.50

    Medication Name: Mellitofix Met 500/5mg 30 Tablets Active Ingredients: Empagliflozin 5 mg Metformin Hydrochloride 500 mg Pharmacological Class:Combination of SGLT2 inhibitor and biguanide antidiabetic agent Indication:Used in adults with type 2 diabetes mellitus to improve glycemic control when treatment with both empagliflozin and metformin is appropriate, as an adjunct to diet and exercise. Dosage:One tablet…

End of content

End of content